Waitr - WTRH Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Waitr in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" WTRH shares.
View WTRH analyst ratings or view top-rated stocks.

1 equities research analysts have issued 12 month price objectives for Waitr's shares. Their WTRH share price forecasts range from $2.00 to $2.00. On average, they expect the company's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 426.3% from the stock's current price.
View analysts price targets for WTRH or view top-rated stocks among Wall Street analysts.

Waitr's stock was trading at $0.74 at the beginning of the year. Since then, WTRH stock has decreased by 48.6% and is now trading at $0.38.
View the best growth stocks for 2022 here.

Waitr saw a increase in short interest in July. As of July 15th, there was short interest totaling 18,070,000 shares, an increase of 37.1% from the June 30th total of 13,180,000 shares. Based on an average trading volume of 9,560,000 shares, the short-interest ratio is presently 1.9 days.
View Waitr's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our WTRH earnings forecast.

Waitr Holdings Inc. (NASDAQ:WTRH) issued its quarterly earnings data on Monday, August, 9th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.06. The company earned $49.17 million during the quarter, compared to analysts' expectations of $50.30 million. Waitr had a negative net margin of 57.15% and a negative trailing twelve-month return on equity of 25.29%.

16 employees have rated Waitr Chief Executive Officer Carl Grimstad on Glassdoor.com. Carl Grimstad has an approval rating of 58% among the company's employees. This puts Carl Grimstad in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Waitr investors own include Bionano Genomics (BNGO), Outlook Therapeutics (OTLK), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Novan (NOVN), DHT (DHT), iBio (IBIO), OPKO Health (OPK) and Zosano Pharma (ZSAN).

Waitr trades on the NASDAQ under the ticker symbol "WTRH."

Shares of WTRH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of WTRH stock can currently be purchased for approximately $0.38.

Waitr (NASDAQ:WTRH) has a market capitalization of $60.21 million and generates $182.19 million in revenue each year. The company earns $-5,230,000.00 in net income (profit) each year or ($0.54) on an earnings per share basis.

The company employs 1,034 workers across the globe.

Waitr's mailing address is 214 Jefferson Street Suite 200, Lafayette LA, 70501. The official website for the company is www.waitrapp.com. The company can be reached via phone at (337) 534-6881 or via email at waitrir@icrinc.com.